organ transplant

Genome Diagnostics Makes €1M Investment in CRISPR Diagnostics Startup Scope Biosciences

CareDx Patents Deemed Invalid in Court Battle Against Natera, Eurofins Viracor

Natera Inks Distribution Deal With TomaLab for Italy

Medicare Administrative Contractor Palmetto Finalizes Coverage of Molecular Testing for Organ Transplant Rejection

CareDx Acquires European Transplant Surveillance Software Firm BFS Molecular

CareDx Q4 Revenues Up 64 Percent

Roche Receives FDA Clearance for Cobas BKV Test for Use With Urine Samples

Eurofins Viracor, Cleveland Clinic Sign License Deal for Kidney Transplant Rejection Biomarker Test

CareDx Prices $175M Common Stock Offering

At JPM, Natera CEO Lays Out Growth Potential for NIPT, Transplant, Cancer Testing

CareDx Preliminary Q4 Revenues Up 63 Percent, Beat Estimates

CareDx, IDbyDNA Partner to Develop Infectious Disease Dx for Transplant Patients

CGS Administrators Aligns Medicare Coverage for CareDx AlloSure Tests

Natera Expects Further Growth in NIPT as it Expands Use Cases for Cancer, Transplant Tests

Natera Q3 Revenues Up 26 Percent on Increased Testing Volumes

Natera Aims to Improve Prospera Kidney Test After Findings Reveal Cell-Free DNA Changes in Infection